Wakunaga Pharmaceutical To Establish U.S. Factory To Produce Generics
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Wakunaga Pharmaceutical announced April 30 that it will spend ¥1.5 billion to build a factory in California to produce OTC drugs. Wakunaga's goal is to establish OTC production facilities in Japan, the U.S. and Europe. The construction will start in July and is estimated to be completed in November 2011. Wakunaga plans to produce over 100 products in the new facility. (Click here for more - Japanese language)